DICLOFENAC POTASSIUM

DICLOFENAC POTASSIUM was reported 11056 times

DICLOFENAC POTASSIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 135 0.5895
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 381 0.5704
2 HEPATIC ENZYME 81 0.5436
3 C-REACTIVE PROTEIN 489 0.5275
4 LUPUS VULGARIS 658 0.5222
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1016 0.5072
6 SWOLLEN JOINT COUNT 114 0.4560
7 SWOLLEN JOINT COUNT INCREASED 1381 0.4326
8 FACET JOINT SYNDROME 1345 0.4127
9 RHEUMATIC FEVER 1832 0.4106
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 732 0.3529
11 RETINITIS 604 0.3493
12 HYPOCHOLESTEROLAEMIA 120 0.3399
13 DISLOCATION OF VERTEBRA 741 0.3246
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
15 X-RAY ABNORMAL 516 0.2883
16 DUODENAL ULCER PERFORATION 2103 0.2825
17 RHEUMATOID FACTOR POSITIVE 1616 0.2795
18 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 28 0.2667
19 SERONEGATIVE ARTHRITIS 287 0.2504
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1795 0.2503
21 PERIPHERAL VENOUS DISEASE 983 0.2405
22 HELICOBACTER INFECTION 2150 0.2090
23 MUSCLE INJURY 1610 0.1941
24 PORPHYRIA ACUTE 277 0.1930
25 C-REACTIVE PROTEIN ABNORMAL 1196 0.1863
26 PEMPHIGUS 2317 0.1851
27 ACQUIRED PORPHYRIA 13 0.1831
28 BONE EROSION 641 0.1811
29 FOLLICULITIS 1833 0.1746
30 HAND DEFORMITY 2260 0.1721
31 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 95 0.1693
32 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1073 0.1651
33 LIP DRY 1446 0.1590
34 BREAST CANCER STAGE III 1013 0.1563
35 TENDER JOINT COUNT 13 0.1548
36 PERICARDITIS 2249 0.1337
37 SYNOVITIS 2293 0.1270
38 JOINT RANGE OF MOTION DECREASED 1609 0.1199
39 MUSCULOSKELETAL DEFORMITY 28 0.1197
40 HYPERCHOLESTEROLAEMIA 1156 0.1196
41 GRIP STRENGTH DECREASED 973 0.1104
42 DEAFNESS TRANSITORY 93 0.1089
43 WOUND INFECTION 1164 0.1062
44 AUTOIMMUNE DISORDER 1029 0.1055
45 BURSITIS 1252 0.1031
46 GLOSSODYNIA 2295 0.1024
47 RED BLOOD CELL SEDIMENTATION RATE 28 0.1004
48 DEATH NEONATAL 130 0.0934
49 LIVE BIRTH 757 0.0904
50 DRUG TOLERANCE DECREASED 246 0.0875
51 IRRITABLE BOWEL SYNDROME 1851 0.0862
52 WOUND 2384 0.0852
53 BLEPHAROSPASM 537 0.0852
54 FIBROMYALGIA 1972 0.0810
55 ONYCHOMADESIS 331 0.0788
56 LIVER INJURY 1790 0.0729
57 SCIATICA 1140 0.0714
58 SYSTEMIC LUPUS ERYTHEMATOSUS 2495 0.0702
59 EXOSTOSIS 624 0.0683
60 LUPUS-LIKE SYNDROME 604 0.0665
61 MATERNAL EXPOSURE TIMING UNSPECIFIED 244 0.0649
62 TYPE 2 DIABETES MELLITUS 2180 0.0647
63 OBESITY 984 0.0617
64 ONYCHOMYCOSIS 253 0.0576
65 IMPAIRED HEALING 1889 0.0575
66 LOWER LIMB FRACTURE 1088 0.0566
67 OVERLAP SYNDROME 38 0.0543
68 RED BLOOD CELL SEDIMENTATION RATE INCREASED 597 0.0539
69 PSORIATIC ARTHROPATHY 2177 0.0536
70 PRESCRIBED OVERDOSE 1030 0.0532
71 SPONDYLITIS 190 0.0522
72 JOINT DISLOCATION 552 0.0522
73 JOINT DESTRUCTION 81 0.0521
74 WRIST DEFORMITY 32 0.0520
75 WALKING AID USER 342 0.0518
76 NAIL DISORDER 437 0.0499
77 CONTRAINDICATED PRODUCT ADMINISTERED 1493 0.0493
78 PULMONARY FIBROSIS 900 0.0469
79 INFUSION SITE REACTION 140 0.0468
80 FOOT DEFORMITY 500 0.0451
81 HIP ARTHROPLASTY 662 0.0432
82 BREAST CANCER STAGE II 354 0.0425
83 NAIL OPERATION 17 0.0411
84 ANTIPHOSPHOLIPID ANTIBODIES 8 0.0410
85 PRESCRIBED UNDERDOSE 809 0.0405
86 BLOOD CHOLESTEROL INCREASED 1830 0.0392
87 ARTHROPATHY 2081 0.0374
88 NIGHT SWEATS 1181 0.0366
89 SICCA SYNDROME 7 0.0363
90 LOWER RESPIRATORY TRACT INFECTION 1622 0.0356
91 OSTEOARTHRITIS 1508 0.0355
92 GAIT INABILITY 1188 0.0355
93 ULCER HAEMORRHAGE 240 0.0354
94 VASCULAR ACCESS COMPLICATION 28 0.0346
95 INFUSION RELATED REACTION 2269 0.0342
96 UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE 4 0.0336
97 HEPATIC CIRRHOSIS 616 0.0328
98 BLISTER 1825 0.0325
99 HEPATIC ENZYME INCREASED 2213 0.0324
100 MEAN PLATELET VOLUME DECREASED 27 0.0322
101 THERAPEUTIC PRODUCT EFFECT DECREASED 1405 0.0313
102 SPINAL FUSION SURGERY 124 0.0305
103 FINGER DEFORMITY 148 0.0305
104 CONGENITAL ANOMALY 234 0.0302
105 ROAD TRAFFIC ACCIDENT 1243 0.0297
106 DISCOMFORT 1783 0.0292
107 STOMATITIS 1769 0.0291
108 WHEEZING 1723 0.0290
109 KNEE ARTHROPLASTY 610 0.0289
110 C-REACTIVE PROTEIN INCREASED 1042 0.0286
111 TEMPERATURE REGULATION DISORDER 59 0.0265
112 PUSTULAR PSORIASIS 90 0.0262
113 FUNCTIONAL GASTROINTESTINAL DISORDER 89 0.0257
114 INJURY 1807 0.0257
115 MOBILITY DECREASED 1821 0.0253
116 LUNG DISORDER 1230 0.0251
117 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 430 0.0251
118 PRODUCT LABEL CONFUSION 145 0.0249
119 INFLAMMATION 1284 0.0249
120 COELIAC DISEASE 242 0.0246
121 LIVER DISORDER 1078 0.0243
122 BACK INJURY 263 0.0242
123 SWELLING 2253 0.0240
124 TASTE DISORDER 485 0.0239
125 RHEUMATOID ARTHRITIS 2680 0.0236
126 MUSCULOSKELETAL PAIN 1232 0.0235
127 JOINT STIFFNESS 615 0.0234
128 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 12 0.0229
129 EAR INFECTION 611 0.0229
130 OEDEMA 1242 0.0229
131 LIVER FUNCTION TEST INCREASED 481 0.0224
132 ILL-DEFINED DISORDER 1335 0.0220
133 EYE INJURY 66 0.0217
134 DELIRIUM 749 0.0216
135 DRUG TOLERANCE 109 0.0215
136 INTESTINAL DIAPHRAGM DISEASE 6 0.0215
137 EMBOLIA CUTIS MEDICAMENTOSA 17 0.0214
138 EPILEPSY 641 0.0209
139 INTERSTITIAL GRANULOMATOUS DERMATITIS 4 0.0207
140 DRUG INTOLERANCE 1969 0.0204
141 JOINT SWELLING 2439 0.0202
142 BLOODY DISCHARGE 23 0.0201
143 MATERNAL EXPOSURE DURING PREGNANCY 1781 0.0200
144 MUSCULOSKELETAL STIFFNESS 1748 0.0199
145 TREATMENT FAILURE 1645 0.0198
146 SYNOVIAL DISORDER 9 0.0198
147 NORMAL NEWBORN 105 0.0193
148 PREGNANCY 385 0.0192
149 SHOULDER ARTHROPLASTY 51 0.0189
150 DRY MOUTH 1492 0.0184
151 SLEEP DISORDER 1281 0.0181
152 GENERAL PHYSICAL HEALTH DETERIORATION 2074 0.0179
153 RASH VESICULAR 86 0.0178
154 MEAN CELL VOLUME DECREASED 27 0.0175
155 DRUG-INDUCED LIVER INJURY 549 0.0175
156 INTENTIONAL PRODUCT USE ISSUE 1515 0.0173
157 SPONDYLOARTHROPATHY 10 0.0167
158 THERAPY NON-RESPONDER 747 0.0166
159 EAR PAIN 311 0.0160
160 DISABILITY 307 0.0155
161 MEAN CELL HAEMOGLOBIN DECREASED 28 0.0153
162 GASTROINTESTINAL DISORDER 1327 0.0148
163 SINUSITIS 1448 0.0141
164 DUCTUS ARTERIOSUS STENOSIS FOETAL 6 0.0141
165 EXPOSURE DURING PREGNANCY 876 0.0141
166 OSTEOPOROSIS 576 0.0140
167 ADVERSE REACTION 184 0.0139
168 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 235 0.0138
169 HYPOAESTHESIA 2069 0.0138
170 CONTUSION 1319 0.0137
171 SPINAL STENOSIS 56 0.0136
172 ABDOMINAL DISCOMFORT 2267 0.0135
173 SUSPECTED OFF LABEL USE 61 0.0135
174 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 92 0.0128
175 MIGRAINE 1222 0.0128
176 ROTATOR CUFF REPAIR 21 0.0120
177 POLYCHONDRITIS 5 0.0118
178 MUSCLE SPASTICITY 145 0.0118
179 HYPERSENSITIVITY 2172 0.0117
180 BRONCHIAL HYPERREACTIVITY 14 0.0116
181 INTERNATIONAL NORMALISED RATIO FLUCTUATION 24 0.0116
182 INFECTION 1664 0.0115
183 KOUNIS SYNDROME 26 0.0114
184 PHARYNGITIS 140 0.0113
185 AMNESIA 725 0.0111
186 PRODUCT USED FOR UNKNOWN INDICATION 14 0.0111
187 ALOPECIA 2184 0.0111
188 GENERAL SYMPTOM 82 0.0109
189 FREQUENT BOWEL MOVEMENTS 295 0.0109
190 TENOSYNOVITIS STENOSANS 6 0.0108
191 RESPIRATORY DISORDER 321 0.0107
192 FOOT OPERATION 53 0.0107
193 URTICARIA 1789 0.0107
194 BLOOD CHOLESTEROL 5 0.0105
195 PERIPHERAL SWELLING 1620 0.0105
196 WEIGHT FLUCTUATION 110 0.0105
197 DYSPEPSIA 1006 0.0102
198 CONFUSIONAL STATE 1644 0.0102
199 GASTROINTESTINAL PAIN 111 0.0101
200 HYPERTENSION 2124 0.0100
201 ASTHMA 1121 0.0099
202 MYOSITIS 88 0.0098
203 POLYARTHRITIS 51 0.0097
204 FOETAL DEATH 50 0.0096
205 UPPER RESPIRATORY TRACT INFECTION 440 0.0095
206 NASOPHARYNGITIS 1708 0.0093
207 INFLAMMATORY PAIN 6 0.0088
208 MEDICATION ERROR 485 0.0087
209 PHONOPHOBIA 4 0.0087
210 ABNORMAL LOSS OF WEIGHT 59 0.0086
211 ADVERSE EVENT 786 0.0085
212 ADVERSE DRUG REACTION 755 0.0084
213 MEMORY IMPAIRMENT 1154 0.0084
214 LYME DISEASE 28 0.0084
215 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 401 0.0083
216 WEIGHT INCREASED 1838 0.0082
217 EXCESSIVE EYE BLINKING 12 0.0081
218 BACK DISORDER 132 0.0081
219 IMMUNODEFICIENCY 120 0.0080
220 PRODUCT USE ISSUE 1486 0.0079
221 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 556 0.0078
222 ANKYLOSING SPONDYLITIS 103 0.0078
223 GASTROOESOPHAGEAL REFLUX DISEASE 624 0.0077
224 MONOCYTE COUNT INCREASED 28 0.0077
225 PULMONARY FUNCTION TEST ABNORMAL 12 0.0077
226 MUSCULAR WEAKNESS 865 0.0076
227 TENDERNESS 79 0.0076
228 MILIARIA 13 0.0076
229 DECREASED APPETITE 1703 0.0073
230 OEDEMA PERIPHERAL 877 0.0072
231 ABDOMINAL PAIN UPPER 1465 0.0071
232 FOOD ALLERGY 54 0.0070
233 COLITIS ULCERATIVE 309 0.0069
234 SACROILIITIS 13 0.0069
235 ARTHRITIS 535 0.0068
236 PARAESTHESIA 1068 0.0068
237 BONE MARROW OEDEMA 7 0.0068
238 RECTAL HAEMORRHAGE 283 0.0066
239 MUSCLE SPASMS 1194 0.0065
240 PRODUCT USE IN UNAPPROVED INDICATION 1603 0.0065
241 DIAPHRAGMATIC HERNIA 4 0.0065
242 HEPATITIS 165 0.0064
243 CHEST PAIN 1169 0.0063
244 POST-TRAUMATIC NECK SYNDROME 5 0.0062
245 WHITE BLOOD CELL COUNT INCREASED 236 0.0061
246 DACTYLITIS 6 0.0061
247 LABORATORY TEST ABNORMAL 179 0.0061
248 CONDITION AGGRAVATED 1843 0.0061
249 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
250 RASH 2544 0.0058
251 NON-ALCOHOLIC STEATOHEPATITIS 6 0.0058
252 PRE-EXISTING CONDITION IMPROVED 36 0.0058
253 PHYSICAL DISABILITY 25 0.0056
254 CATAPLEXY 8 0.0056
255 ALLERGY TO CHEMICALS 7 0.0056
256 CERVICAL RADICULOPATHY 4 0.0056
257 JOINT ARTHROPLASTY 10 0.0056
258 GLOMERULONEPHRITIS MINIMAL LESION 4 0.0055
259 SOFT TISSUE INJURY 4 0.0053
260 ARTHRALGIA 2186 0.0053
261 PANCREATITIS 277 0.0052
262 UNDERDOSE 381 0.0052
263 THERAPEUTIC RESPONSE DECREASED 315 0.0052
264 NECK PAIN 287 0.0051
265 IRON DEFICIENCY 23 0.0051
266 FEELING HOT 313 0.0051
267 MASTOIDITIS 5 0.0051
268 GAIT DISTURBANCE 972 0.0051
269 JOINT EFFUSION 35 0.0051
270 HYPERTRANSAMINASAEMIA 35 0.0050
271 VISUAL IMPAIRMENT 619 0.0050
272 PRODUCT DIFFICULT TO SWALLOW 5 0.0049
273 MUSCULOSKELETAL DISORDER 93 0.0049
274 DEPRESSION 1106 0.0049
275 ADRENAL INSUFFICIENCY 58 0.0048
276 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 11 0.0048
277 FEEDING DISORDER 96 0.0047
278 FLUID RETENTION 235 0.0046
279 INSOMNIA 1213 0.0045
280 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 8 0.0045
281 ENTHESOPATHY 7 0.0045
282 VULVOVAGINAL CANDIDIASIS 6 0.0044
283 PYREXIA 1530 0.0044
284 NASAL ULCER 7 0.0044
285 ANEURYSM RUPTURED 4 0.0044
286 VOMITING 2043 0.0043
287 PRODUCT CONTAMINATION PHYSICAL 11 0.0043
288 PLATELET COUNT INCREASED 55 0.0042
289 BREAST CANCER STAGE I 39 0.0042
290 PAIN 2562 0.0042
291 BRONCHITIS 302 0.0041
292 PAIN IN EXTREMITY 1179 0.0040
293 DEAFNESS 103 0.0039
294 RUBBER SENSITIVITY 6 0.0039
295 ISCHAEMIC CARDIOMYOPATHY 12 0.0039
296 MENOPAUSE 10 0.0039
297 INJECTION SITE REACTION 267 0.0039
298 PRURITUS 1489 0.0039
299 DEFORMITY 36 0.0038
300 MALAISE 1684 0.0038
301 APPLICATION SITE PARAESTHESIA 5 0.0038
302 HYPOPHAGIA 98 0.0038
303 TACHYCARDIA 337 0.0038
304 ASTHENIA 1422 0.0038
305 APPLICATION SITE PAPULES 4 0.0038
306 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 10 0.0038
307 SCLERITIS 6 0.0037
308 PRODUCT QUALITY ISSUE 508 0.0037
309 ANXIETY 1041 0.0037
310 PSORIASIS 469 0.0036
311 PNEUMONIA 1155 0.0036
312 HAEMANGIOMA 8 0.0035
313 HEADACHE 2167 0.0035
314 FATIGUE 2666 0.0034
315 HANGOVER 12 0.0034
316 DIZZINESS 1701 0.0034
317 WEIGHT DECREASED 951 0.0034
318 ABDOMINAL PAIN 777 0.0033
319 ASPIRATION 35 0.0032
320 SEDATION 83 0.0032
321 BODY TEMPERATURE INCREASED 64 0.0031
322 PREGNANCY AFTER POST COITAL CONTRACEPTION 7 0.0031
323 PRODUCT CONTAMINATION 11 0.0031
324 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 166 0.0030
325 CREPITATIONS 9 0.0030
326 OFF LABEL USE 2603 0.0030
327 PRODUCT TASTE ABNORMAL 39 0.0029
328 TERMINAL INSOMNIA 5 0.0028
329 INCORRECT PRODUCT ADMINISTRATION DURATION 61 0.0028
330 APPLICATION SITE DISCOMFORT 5 0.0028
331 FOETAL EXPOSURE DURING PREGNANCY 226 0.0028
332 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
333 DYSPNOEA 1550 0.0027
334 AURA 5 0.0027
335 DIARRHOEA 1706 0.0026
336 BLOOD CREATININE DECREASED 8 0.0026
337 MOVEMENT DISORDER 82 0.0026
338 RHEUMATOID NODULE 7 0.0025
339 TENOSYNOVITIS 7 0.0025
340 PLEURITIC PAIN 7 0.0025
341 MUSCLE CONTRACTURE 5 0.0025
342 NIGHTMARE 85 0.0025
343 BREATH SOUNDS ABNORMAL 12 0.0024
344 OVERWEIGHT 13 0.0024
345 SYNOVIAL CYST 11 0.0024
346 SPINAL DEFORMITY 4 0.0024
347 FOOD AVERSION 4 0.0024
348 CONCUSSION 18 0.0023
349 LYMPHOCYTOSIS 5 0.0023
350 NAUSEA 1835 0.0023
351 INFUSION SITE DISCHARGE 4 0.0023
352 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0023
353 PROTEIN TOTAL INCREASED 6 0.0023
354 PANCREATIC DISORDER 11 0.0022
355 DRUG INEFFECTIVE 2918 0.0022
356 GASTRIC ULCER 42 0.0022
357 ULCERATIVE KERATITIS 6 0.0022
358 CUSHINGOID 7 0.0022
359 NEPHROLITHIASIS 100 0.0022
360 INFECTED SKIN ULCER 4 0.0021
361 DRUG PRESCRIBING ERROR 40 0.0021
362 INTENTIONAL PRODUCT MISUSE 179 0.0020
363 RHINITIS ALLERGIC 9 0.0020
364 SECRETION DISCHARGE 25 0.0020
365 EATING DISORDER 42 0.0020
366 APPLICATION SITE DISCOLOURATION 8 0.0020
367 IMPAIRED WORK ABILITY 42 0.0020
368 IMPAIRED SELF-CARE 4 0.0019
369 BODY TEMPERATURE FLUCTUATION 4 0.0019
370 PAIN IN JAW 54 0.0019
371 ATTENTION DEFICIT HYPERACTIVITY DISORDER 8 0.0019
372 RESPIRATORY TRACT INFECTION 49 0.0019
373 TENSION HEADACHE 8 0.0019
374 DEREALISATION 4 0.0019
375 SNORING 7 0.0018
376 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
377 DECREASED IMMUNE RESPONSIVENESS 18 0.0018
378 DERMATITIS ALLERGIC 23 0.0018
379 APPLICATION SITE BURN 9 0.0018
380 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0018
381 GASTROINTESTINAL ULCER 4 0.0018
382 DERMATITIS EXFOLIATIVE 9 0.0018
383 APPLICATION SITE URTICARIA 4 0.0018
384 ABDOMINAL DISTENSION 186 0.0018
385 PRODUCT COLOUR ISSUE 9 0.0018
386 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
387 THROMBOCYTOPENIA 193 0.0017
388 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
389 PHOTOPHOBIA 32 0.0017
390 BRAIN INJURY 17 0.0017
391 RASH PRURITIC 90 0.0017
392 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
393 HOSPITALISATION 246 0.0016
394 HYPERPARATHYROIDISM SECONDARY 4 0.0016
395 INFUSION SITE PRURITUS 5 0.0016
396 DRUG ERUPTION 28 0.0016
397 RASH ERYTHEMATOUS 74 0.0015
398 POOR VENOUS ACCESS 16 0.0015
399 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
400 INCREASED TENDENCY TO BRUISE 14 0.0015
401 RADICULOPATHY 4 0.0015
402 TREATMENT NONCOMPLIANCE 82 0.0015
403 PLANTAR FASCIITIS 5 0.0015
404 VAGINAL INFECTION 7 0.0015
405 SPINAL DISORDER 14 0.0015
406 TACHYPHRENIA 5 0.0014
407 ENDOTRACHEAL INTUBATION 4 0.0014
408 PHOTOPSIA 9 0.0014
409 STAPHYLOCOCCAL SEPSIS 7 0.0014
410 SLEEP APNOEA SYNDROME 27 0.0014
411 INJECTION SITE SCAR 4 0.0014
412 NECK INJURY 4 0.0014
413 AUTOIMMUNE THYROIDITIS 5 0.0013
414 IRITIS 4 0.0013
415 BACK PAIN 303 0.0013
416 INFUSION SITE EXTRAVASATION 8 0.0013
417 GASTROENTERITIS VIRAL 23 0.0013
418 PHOTOSENSITIVITY REACTION 21 0.0013
419 INFUSION SITE SWELLING 8 0.0013
420 HYPERHIDROSIS 161 0.0012
421 GALLBLADDER OPERATION 5 0.0012
422 MUSCULOSKELETAL DISCOMFORT 21 0.0012
423 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
424 HYPOKALAEMIA 56 0.0012
425 OTITIS MEDIA 4 0.0012
426 PEPTIC ULCER 4 0.0012
427 HEPATIC ENZYME ABNORMAL 6 0.0012
428 LEUKOPENIA 60 0.0012
429 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
430 RETCHING 25 0.0012
431 TEMPERATURE INTOLERANCE 12 0.0012
432 ONYCHOCLASIS 8 0.0012
433 SKIN INFECTION 13 0.0012
434 LARGE INTESTINE PERFORATION 8 0.0012
435 STAPHYLOCOCCAL INFECTION 38 0.0012
436 DYSPHEMIA 5 0.0011
437 MOUTH ULCERATION 24 0.0011
438 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 7 0.0011
439 RENAL CYST 9 0.0011
440 HAEMORRHAGIC DIATHESIS 4 0.0011
441 CONJUNCTIVAL HYPERAEMIA 4 0.0011
442 QUALITY OF LIFE DECREASED 15 0.0011
443 SPINAL PAIN 13 0.0011
444 POST PROCEDURAL INFECTION 9 0.0011
445 ANKLE FRACTURE 17 0.0011
446 ACCIDENTAL OVERDOSE 40 0.0011
447 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
448 ARTHROPOD BITE 8 0.0011
449 GASTRITIS EROSIVE 5 0.0011
450 INITIAL INSOMNIA 11 0.0011
451 BEDRIDDEN 14 0.0011
452 SPINAL COLUMN STENOSIS 5 0.0011
453 PRODUCT ODOUR ABNORMAL 11 0.0010
454 NEUROLOGICAL SYMPTOM 6 0.0010
455 ATELECTASIS 10 0.0010
456 ANAPHYLACTIC REACTION 57 0.0010
457 FALL 343 0.0010
458 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
459 LIGAMENT SPRAIN 10 0.0010
460 OVERDOSE 218 0.0010
461 TRIGEMINAL NEURALGIA 4 0.0010
462 BRONCHOSPASM 14 0.0010
463 APPLICATION SITE EXFOLIATION 4 0.0010
464 MUSCULOSKELETAL CHEST PAIN 15 0.0010
465 ERYTHEMA MULTIFORME 9 0.0010
466 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
467 HALLUCINATIONS, MIXED 4 0.0010
468 CARDIOMYOPATHY 14 0.0009
469 PRODUCT COMPLAINT 24 0.0009
470 EYE DISORDER 31 0.0009
471 SHOULDER OPERATION 4 0.0009
472 BRUXISM 5 0.0009
473 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
474 EYE PAIN 52 0.0009
475 PHARYNGEAL SWELLING 9 0.0009
476 NODULE 12 0.0009
477 SEASONAL ALLERGY 13 0.0009
478 HYDROCEPHALUS 5 0.0009
479 CONJUNCTIVITIS 17 0.0009
480 BODY TEMPERATURE DECREASED 9 0.0009
481 SOMNAMBULISM 6 0.0009
482 EOSINOPHILIA 16 0.0009
483 ORAL CANDIDIASIS 12 0.0009
484 FOOT FRACTURE 17 0.0009
485 ANGIOPATHY 5 0.0009
486 DYSSTASIA 26 0.0009
487 SINUS CONGESTION 12 0.0009
488 FURUNCLE 7 0.0009
489 BLOOD ALBUMIN DECREASED 7 0.0009
490 TRICUSPID VALVE INCOMPETENCE 7 0.0009
491 IMPAIRED GASTRIC EMPTYING 12 0.0009
492 EXERCISE TOLERANCE DECREASED 5 0.0009
493 RHINITIS 7 0.0009
494 NEPHROGENIC ANAEMIA 4 0.0009
495 ROSACEA 4 0.0009
496 ILLNESS 88 0.0009
497 FLANK PAIN 8 0.0009
498 SKIN REACTION 12 0.0009
499 SKIN ABRASION 4 0.0008
500 ENDOMETRIOSIS 4 0.0008
501 DERMATITIS BULLOUS 6 0.0008
502 BIPOLAR DISORDER 9 0.0008
503 RESTLESS LEGS SYNDROME 15 0.0008
504 BONE DISORDER 15 0.0008
505 DRY EYE 41 0.0008
506 DISEASE RECURRENCE 39 0.0008
507 VITAMIN D DECREASED 7 0.0008
508 ANAPHYLACTIC SHOCK 21 0.0008
509 NERVE INJURY 9 0.0008
510 HYPERVOLAEMIA 4 0.0008
511 HYSTERECTOMY 7 0.0008
512 SCOLIOSIS 5 0.0008
513 SPINAL OSTEOARTHRITIS 7 0.0008
514 TOOTH ABSCESS 8 0.0008
515 CARPAL TUNNEL SYNDROME 11 0.0008
516 BURNING SENSATION 55 0.0008
517 NEURALGIA 19 0.0008
518 END STAGE RENAL DISEASE 14 0.0008
519 LOSS OF CONSCIOUSNESS 98 0.0008
520 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
521 PRODUCT PRESCRIBING ERROR 18 0.0008
522 NEPHROPATHY 7 0.0007
523 LIMB DISCOMFORT 23 0.0007
524 POOR QUALITY SLEEP 16 0.0007
525 METASTASES TO LYMPH NODES 5 0.0007
526 LIMB INJURY 20 0.0007
527 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 132 0.0007
528 GASTRIC DISORDER 25 0.0007
529 CYST 9 0.0007
530 DRUG EFFECT DECREASED 39 0.0007
531 PRODUCT PHYSICAL CONSISTENCY ISSUE 4 0.0007
532 CYSTITIS 23 0.0007
533 HEART RATE ABNORMAL 4 0.0007
534 APHONIA 10 0.0007
535 HAEMATEMESIS 18 0.0007
536 EJECTION FRACTION DECREASED 11 0.0007
537 SINUS DISORDER 14 0.0007
538 HAND FRACTURE 5 0.0007
539 THERMAL BURN 5 0.0007
540 GENERALISED ERYTHEMA 4 0.0007
541 INTERNAL HAEMORRHAGE 8 0.0007
542 HEPATIC STEATOSIS 13 0.0007
543 PRURITUS GENERALISED 15 0.0007
544 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
545 RESPIRATORY TRACT CONGESTION 11 0.0007
546 ULCER 11 0.0007
547 TONGUE DISORDER 5 0.0007
548 THROAT IRRITATION 31 0.0007
549 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
550 BLOOD URINE PRESENT 13 0.0007
551 GASTRITIS 18 0.0007
552 DEEP VEIN THROMBOSIS 44 0.0007
553 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
554 BLOOD IRON DECREASED 8 0.0007
555 FEELING DRUNK 5 0.0007
556 SNEEZING 15 0.0007
557 SYMPTOM RECURRENCE 4 0.0007
558 BLOOD PRESSURE FLUCTUATION 16 0.0007
559 UVEITIS 9 0.0007
560 TENSION 4 0.0007
561 SKIN LESION 18 0.0007
562 JOINT INJURY 14 0.0007
563 BODY HEIGHT DECREASED 7 0.0007
564 NERVE COMPRESSION 6 0.0006
565 SPINAL OPERATION 8 0.0006
566 PRODUCTIVE COUGH 31 0.0006
567 PIGMENTATION DISORDER 4 0.0006
568 PRODUCT DISTRIBUTION ISSUE 6 0.0006
569 PHARYNGITIS STREPTOCOCCAL 7 0.0006
570 APHTHOUS ULCER 5 0.0006
571 SKIN LACERATION 7 0.0006
572 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
573 SUICIDAL IDEATION 58 0.0006
574 SURGERY 37 0.0006
575 FEELING JITTERY 12 0.0006
576 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
577 PARAESTHESIA ORAL 9 0.0006
578 AFFECT LABILITY 6 0.0006
579 HEAD DISCOMFORT 11 0.0006
580 SKIN ULCER 16 0.0006
581 CHRONIC KIDNEY DISEASE 47 0.0006
582 INCOHERENT 4 0.0006
583 HEPATITIS ACUTE 4 0.0006
584 VITAMIN D DEFICIENCY 6 0.0006
585 ORAL HERPES 12 0.0006
586 TENDON DISORDER 4 0.0006
587 CHOLECYSTECTOMY 7 0.0006
588 RENAL TUBULAR NECROSIS 6 0.0006
589 ANHEDONIA 16 0.0006
590 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
591 PRODUCT FORMULATION ISSUE 4 0.0006
592 BLOOD PRESSURE INCREASED 92 0.0006
593 OVARIAN CYST 6 0.0006
594 HEART RATE DECREASED 21 0.0006
595 BREAST MASS 4 0.0006
596 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
597 PRODUCT LABEL ISSUE 4 0.0006
598 FACIAL PARALYSIS 5 0.0006
599 STEVENS-JOHNSON SYNDROME 13 0.0006
600 OROPHARYNGEAL PAIN 54 0.0006
601 PSYCHOLOGICAL TRAUMA 5 0.0006
602 LYMPHOEDEMA 4 0.0006
603 BASAL CELL CARCINOMA 9 0.0006
604 PANIC ATTACK 21 0.0006
605 RESPIRATORY RATE INCREASED 5 0.0006
606 APPLICATION SITE IRRITATION 7 0.0006
607 FEAR OF INJECTION 4 0.0006
608 CONSTIPATION 121 0.0006
609 MAJOR DEPRESSION 4 0.0005
610 UTERINE LEIOMYOMA 4 0.0005
611 SWOLLEN TONGUE 17 0.0005
612 HERPES ZOSTER 31 0.0005
613 DIPLOPIA 14 0.0005
614 INFLUENZA 60 0.0005
615 LYMPHADENOPATHY 19 0.0005
616 SOMNOLENCE 108 0.0005
617 MENTAL IMPAIRMENT 13 0.0005
618 CELLULITIS 27 0.0005
619 PAROSMIA 4 0.0005
620 MENTAL DISORDER 23 0.0005
621 HYPOCALCAEMIA 10 0.0005
622 SPUTUM DISCOLOURED 5 0.0005
623 OSTEOPENIA 8 0.0005
624 MICTURITION URGENCY 6 0.0005
625 DIABETES MELLITUS 40 0.0005
626 HERNIA 10 0.0005
627 PALLOR 14 0.0005
628 MULTIPLE ALLERGIES 4 0.0005
629 FUNGAL INFECTION 17 0.0005
630 CYANOSIS 8 0.0005
631 NO ADVERSE EVENT 92 0.0005
632 FAECES DISCOLOURED 11 0.0005
633 SWELLING FACE 33 0.0005
634 HEAD INJURY 16 0.0005
635 FEELING ABNORMAL 121 0.0005
636 NASAL DISCOMFORT 4 0.0005
637 HUNGER 7 0.0005
638 ACCIDENT 6 0.0005
639 MASS 7 0.0005
640 WRIST FRACTURE 6 0.0005
641 HYPONATRAEMIA 28 0.0005
642 BLINDNESS UNILATERAL 7 0.0005
643 LOCALISED INFECTION 12 0.0005
644 PRODUCT PHYSICAL ISSUE 10 0.0005
645 MYASTHENIA GRAVIS 4 0.0005
646 VAGINAL DISCHARGE 5 0.0005
647 SEIZURE 57 0.0005
648 NASAL CONGESTION 29 0.0005
649 SLUGGISHNESS 5 0.0005
650 NEUTROPHIL COUNT INCREASED 5 0.0005
651 ESCHERICHIA INFECTION 4 0.0005
652 DRUG INTERACTION 77 0.0005
653 VIRAL INFECTION 16 0.0005
654 OXYGEN SATURATION DECREASED 27 0.0005
655 DYSARTHRIA 18 0.0005
656 VERTIGO 29 0.0005
657 FRACTURE 9 0.0005
658 INFUSION SITE ERYTHEMA 4 0.0005
659 DEPRESSED MOOD 25 0.0005
660 ERYTHEMA 96 0.0005
661 HIATUS HERNIA 6 0.0005
662 ECONOMIC PROBLEM 7 0.0005
663 PYELONEPHRITIS 4 0.0005
664 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
665 KIDNEY INFECTION 9 0.0005
666 BLOOD CALCIUM INCREASED 4 0.0005
667 LYMPHOMA 7 0.0005
668 EYE HAEMORRHAGE 6 0.0004
669 UNEVALUABLE EVENT 34 0.0004
670 HAIR TEXTURE ABNORMAL 6 0.0004
671 INJECTION SITE URTICARIA 11 0.0004
672 FACIAL PAIN 4 0.0004
673 THROMBOSIS 36 0.0004
674 BRAIN FOG 7 0.0004
675 HAEMARTHROSIS 4 0.0004
676 OSTEOMYELITIS 8 0.0004
677 IMPAIRED DRIVING ABILITY 5 0.0004
678 METABOLIC ACIDOSIS 14 0.0004
679 RIB FRACTURE 9 0.0004
680 PERIPHERAL COLDNESS 6 0.0004
681 IRON DEFICIENCY ANAEMIA 4 0.0004
682 BLOOD POTASSIUM DECREASED 13 0.0004
683 HYPOMAGNESAEMIA 6 0.0004
684 APPENDICITIS 4 0.0004
685 DIARRHOEA HAEMORRHAGIC 4 0.0004
686 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
687 DISTURBANCE IN ATTENTION 23 0.0004
688 COMPLETED SUICIDE 35 0.0004
689 RED BLOOD CELL COUNT DECREASED 12 0.0004
690 APPLICATION SITE ERYTHEMA 11 0.0004
691 RHINORRHOEA 27 0.0004
692 GASTROENTERITIS 6 0.0004
693 RESTLESSNESS 15 0.0004
694 MELAENA 9 0.0004
695 INFLAMMATORY BOWEL DISEASE 4 0.0004
696 HYPOTENSION 82 0.0004
697 APPLICATION SITE PAIN 9 0.0004
698 POLLAKIURIA 17 0.0004
699 KNEE OPERATION 4 0.0004
700 WITHDRAWAL SYNDROME 17 0.0004
701 HEPATOTOXICITY 9 0.0004
702 GENERALISED OEDEMA 5 0.0004
703 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
704 BLOOD PRESSURE ABNORMAL 8 0.0004
705 SPEECH DISORDER 21 0.0004
706 DYSPHAGIA 38 0.0004
707 HYPOAESTHESIA ORAL 6 0.0004
708 LYMPHOCYTE COUNT DECREASED 7 0.0004
709 CARDIAC DISORDER 37 0.0004
710 EYELID PTOSIS 4 0.0004
711 VISION BLURRED 54 0.0004
712 URINARY TRACT INFECTION 67 0.0004
713 SUBARACHNOID HAEMORRHAGE 4 0.0004
714 COUGH 110 0.0004
715 EUPHORIC MOOD 4 0.0004
716 SKIN DISORDER 13 0.0004
717 EAR DISCOMFORT 4 0.0004
718 ROTATOR CUFF SYNDROME 5 0.0004
719 INFUSION SITE PAIN 5 0.0004
720 EXPOSURE VIA SKIN CONTACT 10 0.0004
721 INTENTIONAL DOSE OMISSION 11 0.0004
722 COGNITIVE DISORDER 18 0.0004
723 PETECHIAE 4 0.0004
724 BALANCE DISORDER 33 0.0004
725 IMMUNE SYSTEM DISORDER 5 0.0004
726 PNEUMOTHORAX 6 0.0004
727 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
728 HEREDITARY ANGIOEDEMA 4 0.0004
729 MUSCLE TIGHTNESS 6 0.0004
730 RENAL INJURY 11 0.0004
731 SKIN DISCOLOURATION 17 0.0004
732 COLITIS 14 0.0004
733 BLINDNESS 15 0.0004
734 PNEUMONITIS 10 0.0004
735 MULTIPLE FRACTURES 6 0.0004
736 RENAL DISORDER 17 0.0004
737 ABASIA 9 0.0004
738 RESPIRATORY DISTRESS 10 0.0004
739 SYNCOPE 36 0.0004
740 COVID-19 63 0.0004
741 COORDINATION ABNORMAL 5 0.0004
742 OCULAR HYPERAEMIA 17 0.0004
743 CRYING 13 0.0004
744 RASH PAPULAR 8 0.0004
745 BLOOD CALCIUM DECREASED 4 0.0004
746 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
747 HEPATOCELLULAR INJURY 5 0.0004
748 BONE DENSITY DECREASED 11 0.0004
749 DERMATITIS CONTACT 4 0.0004
750 THERAPY CESSATION 18 0.0004
751 DRUG RESISTANCE 9 0.0004
752 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
753 EYE SWELLING 13 0.0003
754 HYPERSOMNIA 10 0.0003
755 IMPAIRED QUALITY OF LIFE 5 0.0003
756 GASTRIC HAEMORRHAGE 4 0.0003
757 MOOD SWINGS 11 0.0003
758 HYPOKINESIA 5 0.0003
759 POST PROCEDURAL HAEMORRHAGE 4 0.0003
760 TREMOR 57 0.0003
761 SEPSIS 38 0.0003
762 ACUTE KIDNEY INJURY 52 0.0003
763 SKIN HAEMORRHAGE 5 0.0003
764 ATAXIA 4 0.0003
765 GALLBLADDER DISORDER 6 0.0003
766 DEATH 289 0.0003
767 CHOLELITHIASIS 11 0.0003
768 HYPERLIPIDAEMIA 4 0.0003
769 THROAT TIGHTNESS 9 0.0003
770 THYROID CANCER 4 0.0003
771 TOOTHACHE 6 0.0003
772 NOCTURIA 4 0.0003
773 MYALGIA 56 0.0003
774 INFLUENZA LIKE ILLNESS 27 0.0003
775 PHARYNGEAL OEDEMA 5 0.0003
776 DIVERTICULITIS 9 0.0003
777 THYROID DISORDER 5 0.0003
778 TENDONITIS 5 0.0003
779 TOOTH EXTRACTION 4 0.0003
780 MIDDLE INSOMNIA 6 0.0003
781 INJECTION SITE DISCOLOURATION 4 0.0003
782 ANGIOEDEMA 14 0.0003
783 NEUROPATHY PERIPHERAL 30 0.0003
784 TOOTH DISORDER 7 0.0003
785 INJECTION SITE IRRITATION 4 0.0003
786 INJECTION SITE BRUISING 25 0.0003
787 POST PROCEDURAL COMPLICATION 6 0.0003
788 MYDRIASIS 4 0.0003
789 GLAUCOMA 6 0.0003
790 PANCREATITIS ACUTE 7 0.0003
791 CARDIO-RESPIRATORY ARREST 13 0.0003
792 CHROMATURIA 7 0.0003
793 DYSGEUSIA 23 0.0003
794 RENAL IMPAIRMENT 26 0.0003
795 RENAL FAILURE 41 0.0003
796 APPLICATION SITE PRURITUS 7 0.0003
797 PALPITATIONS 36 0.0003
798 CHILLS 36 0.0003
799 PRODUCT DOSE OMISSION ISSUE 90 0.0003
800 TINNITUS 14 0.0003
801 TOOTH INFECTION 4 0.0003
802 PULMONARY CONGESTION 4 0.0003
803 DRUG EFFECT INCOMPLETE 11 0.0003
804 BLOOD UREA INCREASED 5 0.0003
805 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
806 PRODUCT ADMINISTRATION ERROR 6 0.0003
807 LETHARGY 17 0.0003
808 WHITE BLOOD CELL COUNT DECREASED 32 0.0003
809 PULMONARY EMBOLISM 28 0.0003
810 DYSPNOEA EXERTIONAL 11 0.0003
811 PRODUCT PREPARATION ERROR 6 0.0003
812 DYSPHONIA 17 0.0003
813 RESPIRATORY ARREST 8 0.0003
814 BONE PAIN 17 0.0003
815 TOOTH LOSS 6 0.0003
816 MULTI-ORGAN FAILURE 5 0.0003
817 PROCEDURAL PAIN 8 0.0003
818 NERVOUS SYSTEM DISORDER 9 0.0003
819 PRESYNCOPE 7 0.0003
820 RHABDOMYOLYSIS 12 0.0003
821 HAEMOPTYSIS 8 0.0003
822 RASH MACULAR 10 0.0003
823 COLD SWEAT 5 0.0003
824 AGEUSIA 7 0.0003
825 PARALYSIS 4 0.0003
826 DISEASE PROGRESSION 33 0.0003
827 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
828 PRODUCT PRESCRIBING ISSUE 6 0.0003
829 LIVER FUNCTION TEST ABNORMAL 8 0.0003
830 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
831 DYSURIA 10 0.0003
832 LIP SWELLING 9 0.0003
833 DEHYDRATION 36 0.0003
834 PULMONARY MASS 4 0.0003
835 THINKING ABNORMAL 5 0.0003
836 ORAL PAIN 6 0.0003
837 NERVOUSNESS 14 0.0003
838 BLOOD SODIUM DECREASED 5 0.0003
839 APHASIA 8 0.0003
840 BLOOD COUNT ABNORMAL 4 0.0003
841 PRODUCT AVAILABILITY ISSUE 6 0.0003
842 HAEMOGLOBIN DECREASED 27 0.0003
843 INSURANCE ISSUE 4 0.0003
844 PRODUCT DOSE OMISSION 17 0.0003
845 RENAL FAILURE ACUTE 11 0.0003
846 HYPERKALAEMIA 9 0.0003
847 THERAPY PARTIAL RESPONDER 4 0.0003
848 SKIN FISSURES 5 0.0003
849 HYPOACUSIS 11 0.0003
850 NEOPLASM MALIGNANT 17 0.0003
851 MENORRHAGIA 5 0.0003
852 HAEMATOCHEZIA 14 0.0003
853 DISORIENTATION 10 0.0003
854 ACCIDENTAL EXPOSURE TO PRODUCT 26 0.0003
855 HOT FLUSH 19 0.0003
856 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
857 MULTIPLE SCLEROSIS 12 0.0003
858 HYPOTHYROIDISM 8 0.0003
859 INTERSTITIAL LUNG DISEASE 12 0.0002
860 FLATULENCE 14 0.0002
861 FLUSHING 25 0.0002
862 CHEST DISCOMFORT 25 0.0002
863 INJECTION SITE MASS 9 0.0002
864 EYE IRRITATION 14 0.0002
865 INJECTION SITE WARMTH 5 0.0002
866 HEART RATE INCREASED 24 0.0002
867 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
868 EXPIRED PRODUCT ADMINISTERED 8 0.0002
869 PULMONARY HYPERTENSION 5 0.0002
870 URINARY RETENTION 8 0.0002
871 EYE PRURITUS 8 0.0002
872 FACE OEDEMA 4 0.0002
873 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
874 IRRITABILITY 14 0.0002
875 PARANOIA 4 0.0002
876 RASH GENERALISED 6 0.0002
877 HAEMATOMA 6 0.0002
878 SUICIDE ATTEMPT 14 0.0002
879 NEOPLASM PROGRESSION 8 0.0002
880 SEPTIC SHOCK 10 0.0002
881 ECZEMA 12 0.0002
882 DRUG ABUSE 19 0.0002
883 EPISTAXIS 17 0.0002
884 HALLUCINATION 17 0.0002
885 PULMONARY OEDEMA 10 0.0002
886 EMOTIONAL DISTRESS 27 0.0002
887 GOUT 4 0.0002
888 PAIN OF SKIN 6 0.0002
889 LEUKOCYTOSIS 4 0.0002
890 PELVIC PAIN 4 0.0002
891 MOOD ALTERED 6 0.0002
892 HYPERGLYCAEMIA 8 0.0002
893 CATARACT 13 0.0002
894 INTENTIONAL OVERDOSE 14 0.0002
895 INJECTION SITE ERYTHEMA 27 0.0002
896 SHOCK 5 0.0002
897 ABNORMAL DREAMS 6 0.0002
898 MUSCLE TWITCHING 5 0.0002
899 CARDIAC FAILURE 17 0.0002
900 DRY SKIN 28 0.0002
901 INJECTION SITE PRURITUS 14 0.0002
902 INJECTION SITE SWELLING 16 0.0002
903 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
904 SEROTONIN SYNDROME 4 0.0002
905 ACUTE RESPIRATORY FAILURE 4 0.0002
906 ANGER 7 0.0002
907 NEEDLE ISSUE 6 0.0002
908 ASCITES 6 0.0002
909 URINARY INCONTINENCE 6 0.0002
910 UPPER LIMB FRACTURE 4 0.0002
911 BLOOD CREATININE INCREASED 13 0.0002
912 INJECTION SITE PAIN 61 0.0002
913 LACRIMATION INCREASED 6 0.0002
914 CORONARY ARTERY DISEASE 6 0.0002
915 ABDOMINAL PAIN LOWER 5 0.0002
916 DYSKINESIA 8 0.0002
917 DRUG ADMINISTRATION ERROR 6 0.0002
918 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
919 FEMUR FRACTURE 6 0.0002
920 UNRESPONSIVE TO STIMULI 5 0.0002
921 HAEMORRHAGE 20 0.0002
922 DERMATITIS ATOPIC 10 0.0002
923 SKIN EXFOLIATION 16 0.0002
924 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
925 HIP FRACTURE 6 0.0002
926 FEAR 5 0.0002
927 JAUNDICE 5 0.0002
928 VAGINAL HAEMORRHAGE 8 0.0002
929 CEREBROVASCULAR ACCIDENT 31 0.0002
930 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
931 TRANSAMINASES INCREASED 4 0.0002
932 RASH MACULO-PAPULAR 4 0.0002
933 PANCYTOPENIA 10 0.0002
934 DEMENTIA 5 0.0002
935 ABORTION SPONTANEOUS 7 0.0002
936 SKIN IRRITATION 8 0.0002
937 ANGINA PECTORIS 5 0.0002
938 ACUTE MYOCARDIAL INFARCTION 5 0.0002
939 COMA 8 0.0002
940 THERAPY INTERRUPTED 12 0.0002
941 BLOOD PRESSURE DECREASED 11 0.0002
942 HYPOGLYCAEMIA 8 0.0002
943 PLEURAL EFFUSION 10 0.0002
944 ENCEPHALOPATHY 4 0.0002
945 ANAEMIA 31 0.0002
946 EMOTIONAL DISORDER 5 0.0002
947 PNEUMONIA ASPIRATION 4 0.0002
948 INTESTINAL OBSTRUCTION 6 0.0002
949 CARDIAC ARREST 13 0.0002
950 LACTIC ACIDOSIS 5 0.0002
951 OSTEONECROSIS 5 0.0002
952 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
953 BREAST CANCER 14 0.0002
954 MENTAL STATUS CHANGES 4 0.0001
955 TOXICITY TO VARIOUS AGENTS 24 0.0001
956 DEVICE MALFUNCTION 10 0.0001
957 HYPOXIA 5 0.0001
958 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
960 DRUG DOSE OMISSION 22 0.0001
961 HEPATIC FAILURE 4 0.0001
962 INCORRECT DOSE ADMINISTERED 30 0.0001
963 INJECTION SITE RASH 4 0.0001
964 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
966 BLOOD GLUCOSE DECREASED 6 0.0001
967 ATRIAL FIBRILLATION 12 0.0001
968 MYOCARDIAL INFARCTION 20 0.0001
969 PRODUCT ADHESION ISSUE 4 0.0001
970 RESPIRATORY FAILURE 8 0.0001
971 AGITATION 8 0.0001
972 FEBRILE NEUTROPENIA 7 0.0001
973 PLASMA CELL MYELOMA 4 0.0001
974 BLOOD GLUCOSE INCREASED 19 0.0001
975 EXTRA DOSE ADMINISTERED 4 0.0001
976 PLATELET COUNT DECREASED 10 0.0001
977 ACNE 7 0.0001
978 INJECTION SITE HAEMORRHAGE 7 0.0001
979 CONVULSION 5 0.0001
980 PRODUCT SUBSTITUTION ISSUE 5 0.0001
981 ARRHYTHMIA 4 0.0001
982 NEUTROPENIA 11 0.0001
983 AGGRESSION 4 0.0001
984 DRUG WITHDRAWAL SYNDROME 7 0.0001
985 BRADYCARDIA 4 0.0001
986 DRUG DEPENDENCE 12 0.0001
987 SKIN BURNING SENSATION 5 0.0001
988 DRUG DOSE OMISSION BY DEVICE 5 0.0001
989 CARDIAC FAILURE CONGESTIVE 5 0.0001
990 DEVICE ISSUE 5 0.0001
991 PROSTATE CANCER 4 0.0000
992 PRODUCT STORAGE ERROR 4 0.0000